AJGP
HOME HELP FEEDBACK SUBSCRIPTIONS ALL ISSUES SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a Colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Furlan, P. M.
Right arrow Articles by Katz, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Furlan, P. M.
Right arrow Articles by Katz, I.
Am J Geriatr Psychiatry 12:323-330, June 2004
© 2004 American Association for Geriatric Psychiatry


Regular Article

SSRIs Do Not Cause Affective Blunting in Healthy Elderly Volunteers

Patricia M. Furlan, Ph.D., Michael J. Kallan, M.S., Thomas Ten Have, Ph.D., Irwin Lucki, Ph.D., and Ira Katz, M.D., Ph.D.

Received June 30, 2003; revised October 3, 2003; accepted November 18, 2003. From the Department of Psychiatry, University of Pennsylvania, Philadelphia, PA (PMF,IL,IK); MIRECC, Philadelphia Veterans Administration Medical Center, Philadelphia, PA (PMF,IK), and the Department of Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA (MJK,TTH). Send correspondence to Ira Katz, M.D., Ph.D., University of Pennsylvania School of Medicine, Department of Psychiatry, 3535 Market Street, Room 3001, Philadelphia, PA 19104. e-mail: katzi{at}mail.med.upenn.edu
© 2004 American Association for Geriatric Psychiatry

Objective: This study was undertaken to evaluate the effects of selective serotonin reuptake inhibitors (SSRIs) on affective experience in healthy older adults. Methods: After 1 week of observation, normal elderly volunteers (age range: 65–84 years) were given placebo, paroxetine (10 mg–40 mg/day), or sertraline (50 mg–150 mg/day) for 3 weeks in a double-blind study. Paroxetine- and sertraline-treated subjects were analyzed together as the SSRI group (N=30). Volunteers were assessed weekly and recorded mood and events in a daily diary each evening. All data were analyzed with mixed-effects random-regression models. Results: There were significant relationships between daily affect and events reported in the daily diary for the sample as a whole, with no differences between groups in mean slopes of positive or negative affect across the length of the study. There were no differences between groups in affective variability. However, the SSRI group, but not the placebo group, demonstrated a significant drug-dependent decrease in negative affect related to negative events. There were no other observed group differences on any other measure. Conclusion: Interpreting the results conservatively, they demonstrate that SSRIs are not associated with affective toxicity in elderly persons.

Key Words: Depression • SSRIs • Side Effects • Paroxetine • Sertraline




This article has been cited by other articles:


Home page
BiostatisticsHome page
M. R. Elliott
Identifying latent clusters of variability in longitudinal data
Biostat., October 1, 2007; 8(4): 756 - 771.
[Abstract] [Full Text] [PDF]


Home page
AJGPHome page
L. G. Chepenik, T. T. Have, D. Oslin, C. Datto, C. Zubritsky, and I. R. Katz
A Daily Diary Study of Late-Life Depression
Am J Geriatr Psychiatry, March 1, 2006; 14(3): 270 - 279.
[Abstract] [Full Text] [PDF]


Home page
AJGPHome page
D. Weintraub, M. S. Cary, M. B. Stern, D. Taraborelli, and I. R. Katz
Daily Affect in Parkinson Disease Is Responsive to Life Events and Motor Symptoms
Am J Geriatr Psychiatry, February 1, 2006; 14(2): 161 - 168.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ALL ISSUES SEARCH TABLE OF CONTENTS
Copyright © 2004 American Association for Geriatric Psychiatry